Susquehanna International Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.4M Sell
556,200
-27,200
-5% -$4.46M 0.01% 878
2025
Q4
$93M Buy
583,400
+202,800
+53% +$27.8M 0.01% 932
2025
Q3
$35.6M Sell
380,600
-40,300
-10% -$2.85M ﹤0.01% 1632
2025
Q2
$24M Buy
420,900
+102,800
+32% +$5.45M ﹤0.01% 1821
2025
Q1
$19.4M Sell
318,100
-95,300
-23% -$8.12M ﹤0.01% 1767
2024
Q4
$37.2M Buy
413,400
+162,100
+65% +$19.1M 0.01% 1341
2024
Q3
$32.4M Buy
251,300
+43,100
+21% +$5.62M 0.01% 1411
2024
Q2
$23.6M Sell
208,200
-76,000
-27% -$8.14M ﹤0.01% 1565
2024
Q1
$37.7M Sell
284,200
-53,300
-16% -$6.96M 0.01% 1227
2023
Q4
$41.2M Buy
337,500
+254,505
+307% +$19.5M 0.01% 1174
2023
Q3
$6.32M Sell
82,995
-41,180
-33% -$4.23M ﹤0.01% 3170
2023
Q2
$14.7M Buy
124,175
+50,445
+68% +$6.29M ﹤0.01% 2052
2023
Q1
$7.27M Buy
73,730
+10,195
+16% +$1.38M ﹤0.01% 2908
2022
Q4
$8.98M Sell
63,535
-2,870
-4% -$400K ﹤0.01% 2412
2022
Q3
$9.31M Sell
66,405
-6,285
-9% -$1.15M ﹤0.01% 2251
2022
Q2
$9.8M Sell
72,690
-2,515
-3% -$428K ﹤0.01% 2223
2022
Q1
$23.6M Buy
75,205
+23,090
+44% +$8.7M ﹤0.01% 1572
2021
Q4
$37.5M Sell
52,115
-4,465
-8% -$4.27M 0.01% 1308
2021
Q3
$62.6M Buy
56,580
+2,865
+5% +$3.52M 0.01% 1017
2021
Q2
$79.1M Buy
53,715
+25,075
+88% +$34.8M 0.01% 905
2021
Q1
$45.2M Buy
28,640
+4,355
+18% +$10.2M 0.01% 1180
2020
Q4
$48.8M Sell
24,285
-9,445
-28% -$15.1M 0.01% 1025
2020
Q3
$36.1M Buy
33,730
+6,760
+25% +$7.75M 0.01% 1049
2020
Q2
$32.1M Buy
26,970
+10,670
+65% +$9.25M 0.01% 1078
2020
Q1
$7.35M Sell
16,300
-5,175
-24% -$4.71M ﹤0.01% 2101
2019
Q4
$24.7M Sell
21,475
-215
-1% -$193K 0.01% 1244
2019
Q3
$13.4M Buy
21,690
+480
+2% +$399K ﹤0.01% 1681
2019
Q2
$21.3M Buy
21,210
+11,070
+109% +$10.7M 0.01% 1231
2019
Q1
$12.1M Sell
10,140
-1,115
-10% -$1.16M 0.01% 1561
2018
Q4
$7.4M Sell
11,255
-2,340
-17% -$2.45M ﹤0.01% 1880
2018
Q3
$25.3M Sell
13,595
-6,780
-33% -$13.3M 0.01% 1149
2018
Q2
$38.7M Buy
20,375
+7,595
+59% +$13.4M 0.01% 820
2018
Q1
$20.3M Sell
12,780
-5,775
-31% -$10.8M 0.01% 1200
2017
Q4
$28.9M Buy
18,555
+3,820
+26% +$5.85M 0.01% 1004
2017
Q3
$25.2M Buy
14,735
+6,010
+69% +$8.34M 0.01% 1059
2017
Q2
$11M Sell
8,725
-85
-1% -$85.8K ﹤0.01% 1622
2017
Q1
$8.41M Sell
8,810
-9,260
-51% -$8.25M ﹤0.01% 1786
2016
Q4
$11.3M Sell
18,070
-11,145
-38% -$8.37M 0.01% 1446
2016
Q3
$28.5M Buy
29,215
+15,565
+114% +$12.8M 0.01% 793
2016
Q2
$7.7M Buy
13,650
+11,600
+566% +$7.27M ﹤0.01% 1695
2016
Q1
$1.12M Buy
2,050
+1,894
+1,214% +$1.2M ﹤0.01% 4850
2015
Q4
$265K Buy
+156
New +$253K ﹤0.01% 7924

Other funds holding LABU

Susquehanna International Group's LABU Position: Q1 2026 in Review

Susquehanna International Group increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 24% in Q1 2026, buying an estimated $2.12M and bringing the position to 67,050 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Susquehanna International Group first reported a position in LABU in Q2 2015 and has held it in 31 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Susquehanna International Group held 67,050 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $11.1M as of Q1 2026.
  • Susquehanna International Group bought 12,910 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $2.12M.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2955 holding.
  • Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2015 and has held it in 31 quarters since.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.